102 related articles for article (PubMed ID: 18586873)
1. Clinicopathologic findings in polypoidal choroidal vasculopathy.
Nakashizuka H; Mitsumata M; Okisaka S; Shimada H; Kawamura A; Mori R; Yuzawa M
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4729-37. PubMed ID: 18586873
[TBL] [Abstract][Full Text] [Related]
2. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment.
Koh AH; ; Chen LJ; Chen SJ; Chen Y; Giridhar A; Iida T; Kim H; Yuk Yau Lai T; Lee WK; Li X; Han Lim T; Ruamviboonsuk P; Sharma T; Tang S; Yuzawa M
Retina; 2013 Apr; 33(4):686-716. PubMed ID: 23455233
[TBL] [Abstract][Full Text] [Related]
3. Pachychoroid pigment epitheliopathy.
Warrow DJ; Hoang QV; Freund KB
Retina; 2013 Sep; 33(8):1659-72. PubMed ID: 23751942
[TBL] [Abstract][Full Text] [Related]
4. The expanded spectrum of focal choroidal excavation.
Margolis R; Mukkamala SK; Jampol LM; Spaide RF; Ober MD; Sorenson JA; Gentile RC; Miller JA; Sherman J; Freund KB
Arch Ophthalmol; 2011 Oct; 129(10):1320-5. PubMed ID: 21670327
[TBL] [Abstract][Full Text] [Related]
5. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.
Cheung CMG; Lai TYY; Ruamviboonsuk P; Chen SJ; Chen Y; Freund KB; Gomi F; Koh AH; Lee WK; Wong TY
Ophthalmology; 2018 May; 125(5):708-724. PubMed ID: 29331556
[TBL] [Abstract][Full Text] [Related]
6. Pachychoroid spectrum disease.
Borooah S; Sim PY; Phatak S; Moraes G; Wu CY; Cheung CMG; Pal B; Bujarborua D
Acta Ophthalmol; 2021 Sep; 99(6):e806-e822. PubMed ID: 33258304
[TBL] [Abstract][Full Text] [Related]
7. DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Chang YC; Cheng CK
Retina; 2020 Jul; 40(7):1403-1411. PubMed ID: 31181038
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Hypoxia-Inducible Factors and Vascular Endothelial Growth Factor Expressions by Superfood Camu-Camu (
Nakai A; Lee D; Shoda C; Negishi K; Nakashizuka H; Yamagami S; Kurihara T
J Ophthalmol; 2023; 2023():6617981. PubMed ID: 38187496
[TBL] [Abstract][Full Text] [Related]
9. Macular neovascularization and polypoidal choroidal vasculopathy: phenotypic variations, pathogenic mechanisms and implications in management.
Cheung CMG
Eye (Lond); 2024 Mar; 38(4):659-667. PubMed ID: 37803144
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Imaging Polypoidal Choroidal Vasculopathy with Swept-Source Optical Coherence Tomography Angiography.
Gu X; Zhao X; Zhao Q; Wang Y; Chen Y
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510200
[TBL] [Abstract][Full Text] [Related]
11. New Concepts for the Diagnosis of Polypoidal Choroidal Vasculopathy.
Zhao J; Chandrasekaran PR; Cheong KX; Wong M; Teo K
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238165
[TBL] [Abstract][Full Text] [Related]
12. Visual impairment associated with choroidal macroaneurysm in a patient with presumed anomalous short posterior ciliary artery.
Kinoshita T; Mori J; Imaizumi H
Am J Ophthalmol Case Rep; 2022 Dec; 28():101755. PubMed ID: 36439652
[TBL] [Abstract][Full Text] [Related]
13. Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Mao J; Chen N; Zhang S; Fang Y; Zheng Z; Wu S; Ye X; Chen Y; Chen Y; Shen L
Front Med (Lausanne); 2022; 9():973025. PubMed ID: 36213652
[TBL] [Abstract][Full Text] [Related]
14. Chorioretinal abnormalities in idiopathic intracranial hypertension: case reports.
Ariello LE; Mello LGM; Pimentel SLG; Monteiro MLR
Int J Retina Vitreous; 2022 Jul; 8(1):48. PubMed ID: 35869502
[TBL] [Abstract][Full Text] [Related]
15. Imaging Characteristics of Neovascular and Atrophic Pachychoroidal Spectrum Diseases.
Hua R; Zhang M
Front Med (Lausanne); 2022; 9():891397. PubMed ID: 35860744
[TBL] [Abstract][Full Text] [Related]
16. Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept.
Xue Y; Qinhua C
Front Med (Lausanne); 2022; 9():835255. PubMed ID: 35252267
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography in diagnosing polypoidal choroidal vasculopathy. Looking into the future: a systematic review and meta-analysis.
Permadi AC; Djatikusumo A; Adriono GA
Int J Retina Vitreous; 2022 Feb; 8(1):14. PubMed ID: 35227320
[TBL] [Abstract][Full Text] [Related]
18. Treatment of old submacular hemorrhage by subretinal endoscopic surgery and intraoperative subretinal endoscopic findings.
Yokoyama S; Kaga T; Kojima T; Orellana-Rios J; Smith RT; Ichikawa K
Am J Ophthalmol Case Rep; 2022 Mar; 25():101393. PubMed ID: 35198817
[TBL] [Abstract][Full Text] [Related]
19. Publication Trends of Research on Polypoidal Choroidal Vasculopathy During 2001-2020: A 20-Year Bibliometric Study.
Wang Y; Xie M; Zhang M; Zhao X; Zhu X; Wang Y; Chen Y; Chen J; Sun X
Front Med (Lausanne); 2021; 8():785126. PubMed ID: 35174182
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological study of the polypoidal lesions of polypoidal choroidal vasculopathy.
Liu G; Han L; Lu Y; Wang C; Ma L; Zhang P; Liu C; Lu X; Ma Z
Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2369-2377. PubMed ID: 35147748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
